Lee's Pharmaceutical Holdings Limited (HKG:0950)
Hong Kong · Delayed Price · Currency is HKD
1.210
-0.030 (-2.42%)
Apr 2, 2026, 4:08 PM HKT
Revenue by Segment
Financials in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 |
|---|
| | 553.24M | 467.28M | 733.34M | 749.14M | 677.95M | | | | |
Licensed-In Products Growth | | 18.40% | -36.28% | -2.11% | 10.50% | -0.78% | | | | |
Proprietary and Generic Products | | 846.73M | 585.76M | 499.81M | 517.02M | 538.77M | | | | |
Proprietary and Generic Products Growth | | 44.55% | 17.20% | -3.33% | -4.04% | 0.59% | | | | |
| | 1.40B | 1.05B | 1.23B | 1.27B | 1.22B | | | | |
| | 32.95% | -14.61% | -2.61% | 4.06% | -0.18% | | | | |
Revenue by Geography
Financials in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 |
|---|
The People's Republic of China (The PRC) | | 1.40B | 1.05B | 1.23B | 1.27B | 1.22B | | | | |
The People's Republic of China (The PRC) Growth | | 32.95% | -14.61% | -2.61% | 4.06% | -0.18% | | | | |
| | 1.40B | 1.05B | 1.23B | 1.27B | 1.22B | | | | |
| | 32.95% | -14.61% | -2.61% | 4.06% | -0.18% | | | | |
Source: S&P Global Market Intelligence.
